DLRHX
Price
$22.40
Change
+$0.12 (+0.54%)
Updated
Aug 1 closing price
Net Assets
626.87M
JNGLX
Price
$65.76
Change
+$0.35 (+0.54%)
Updated
Aug 1 closing price
Net Assets
4.4B
Interact to see
Advertisement

DLRHX vs JNGLX

Header iconDLRHX vs JNGLX Comparison
Open Charts DLRHX vs JNGLXBanner chart's image
Macquarie Healthcare R
Price$22.40
Change+$0.12 (+0.54%)
VolumeN/A
Net Assets626.87M
Janus Henderson Global Life Sciences D
Price$65.76
Change+$0.35 (+0.54%)
VolumeN/A
Net Assets4.4B
DLRHX vs JNGLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLRHX vs. JNGLX commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLRHX is a Hold and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. DLRHX (627M). JNGLX pays higher dividends than DLRHX: JNGLX (0.36) vs DLRHX (0.00). DLRHX was incepted earlier than JNGLX: DLRHX (16 years) vs JNGLX (27 years). DLRHX (1.50) is less costly to investors than JNGLX (0.80). JNGLX is a more actively managed with annual turnover of: 35.00 vs. DLRHX (5.00). DLRHX has a lower initial minimum investment than JNGLX: DLRHX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -17.04 vs. DLRHX (-20.80). JNGLX return over 5 years is better than : 2.80 vs. DLRHX (-17.31).
DLRHXJNGLXDLRHX / JNGLX
Total Expense Ratio1.460.80183%
Annual Report Gross Expense Ratio1.500.80188%
Fund Existence16 years27 years-
Gain YTD-3.257-3.65389%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets627M4.4B14%
Annual Yield % from dividends0.000.36-
Returns for 1 year-20.80-17.04122%
Returns for 3 years-11.526.28-183%
Returns for 5 years-17.312.80-618%
Returns for 10 years5.644.66121%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OPGSX36.58N/A
N/A
Invesco Gold & Special Minerals A
CWVGX24.07N/A
N/A
Calvert International Equity A
JGASX44.24N/A
N/A
JPMorgan Growth Advantage I
RSMOX24.59N/A
N/A
Victory RS Mid Cap Growth A
BRSYX14.42N/A
N/A
MFS Blended Research Small Cap Eq R6